ARKK vs CELUW
ARK Innovation ETF (ARKK) versus Celularity Inc (CELUW) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Celularity Inc (CELUW) common stock listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
ARKK currently screens at market cap $0. CELUW currently screens at market cap $0.
Not investment advice. Open the ARKK and CELUW stock pages for the full models.
Not investment advice.